about
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsIs wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activityContraception and abortionContraception technology: past, present and futureEffects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamicsMicrobicides: topical prevention against HIVNanoparticle transport from mouse vagina to adjacent lymph nodesEfficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1HIV/AIDS epidemiology, pathogenesis, prevention, and treatmentMicrobicides and other topical agents in the prevention of HIV and sexually transmitted infections.Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.Why primate models matter.Which topical microbicides for blocking HIV-1 transmission will work in the real world?Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.Targeting Trojan Horse leukocytes for HIV prevention.Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cellsDevelopment of topical microbicides to prevent the sexual transmission of HIVWhither or wither microbicides?Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.An anti-HIV microbicide comes aliveSafety and anti-HIV assessments of natural vaginal cleansing products in an established topical microbicides in vitro testing algorithm.Quantitative assessment of microbicide-induced injury in the ovine vaginal epithelium using confocal microendoscopy.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.Characterization of commercially available vaginal lubricants: a safety perspective.In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.Minocycline down-regulates topical mucosal inflammation during the application of microbicide candidatesIn vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge modelDecreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safetyHomeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicideDefective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.Topical microbicides to prevent the transmission of HIV: formulation gaps and challengesBiocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.Antiretroviral-based HIV prevention strategies for women.Non-specific microbicide product development: then and nowMicrobial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.Use of high-resolution confocal imaging of the vaginal epithelial microstructure to detect microbicide toxicity.Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.
P2860
Q21090521-6E9D4B41-03FD-4865-BDE1-0E1EBFFDAC7EQ21133918-D37C47FA-FB72-455E-A0E0-46FBEFC78408Q24679808-45F44F50-854A-450A-BC7D-85A01DA84DA1Q26849373-E5BC9E26-10E1-4FB8-AB99-3BC15568AA22Q26998835-3E77156D-82E6-4273-AE52-FA1E8DFB0DFEQ26999403-7475B5EC-14BB-41BF-8493-FA1A3D6EB2F9Q27329123-6C66E7BB-4FF8-43EE-A07B-82DF418563D8Q28729936-694ECADF-0DDD-4DE2-8B70-524B49A461BCQ30356074-9AA35BC8-940B-4C95-A536-E7044A04CE7CQ30359545-17AD829B-D0C2-438B-B68A-31EA23BD3E38Q30412592-FA6DD9E5-E5C6-4A3C-9A47-E11012A0BE22Q30417520-69A8D4F1-3A49-451C-8AA6-6F053FB84ED8Q33253661-E8154528-477D-4DC2-8C63-D8250799F6AFQ33399887-AC7035EA-F272-4130-8B18-FE3592ABD8DEQ33518390-873069C5-2559-4B21-A0CE-64D68281D03AQ33613769-4D9585BF-B540-499C-B893-F759BEC220B0Q33625073-48B945F8-A1A3-42FB-809E-601B2AD6AB88Q33715907-5C1777A3-526B-4676-99E2-ACFBFBDF9EFDQ33750747-11B38763-CB19-489A-AA90-D1685A0EEC80Q33826278-862521B3-8743-402F-A07C-B6A21EF4D2CCQ33828458-4A48DCF3-402D-431F-B701-4BE57FDA74DEQ33934017-79F25EE2-AD29-479C-B3B7-84D94E919F93Q34035880-66D57CAA-02AA-4CA2-A0DB-244F2189F233Q34178386-FB3AAA73-811A-4082-BA74-D3020CC6C60FQ34198191-C0C02E3F-D7F7-4E62-9546-295A6D5388B2Q34309533-E8F9C690-6454-4B43-A13A-8ABC7CCE8528Q34309855-9D5B3AC2-78E4-4C20-9A2C-0166ED678B00Q34352144-77142E47-DF6E-4BCA-8FCC-6983F7603DA4Q34384880-5C6FD5B7-290C-422C-8DE9-F55B02C0D330Q34387113-7F3FAC53-1AC5-418E-A2C5-26AB77364ECCQ34425552-7C77AC43-DCB4-4A4F-86B6-05291C5DE2B9Q34539354-8CF76E35-0A40-467C-A2FC-2367E22516DBQ34720373-8F8F51B9-4885-461E-A2B2-E218CA1B59A5Q35009798-90D5A44B-9FB2-4019-B3FB-0FA96819A451Q35215392-FCC9F746-918B-41A6-9BDF-6FF7C4B56BB5Q35237188-16A75363-098C-4E0C-884C-420F2AF73888Q35345283-8DB9BDDB-F17F-4854-ABA7-5B695F710DD5Q35618379-D56418DB-53D5-44CE-BE1D-CE52EC5575BEQ35854819-79834473-57B1-4B38-8ADB-1B5BEEE1C516Q36018776-6C6E0F48-12F0-4860-BA06-7B17B5B2BE83
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
In vitro and in vivo: the story of nonoxynol 9.
@ast
In vitro and in vivo: the story of nonoxynol 9.
@en
type
label
In vitro and in vivo: the story of nonoxynol 9.
@ast
In vitro and in vivo: the story of nonoxynol 9.
@en
prefLabel
In vitro and in vivo: the story of nonoxynol 9.
@ast
In vitro and in vivo: the story of nonoxynol 9.
@en
P2093
P1476
In vitro and in vivo: the story of nonoxynol 9.
@en
P2093
Fulvia Veronese
Patricia Reichelderfer
Roberta Black
Sharon L Hillier
Thomas Moench
P356
10.1097/01.QAI.0000159671.25950.74
P407
P577
2005-05-01T00:00:00Z